CrossrefInfokarte
Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study
Neurological Disorders and Therapeutics · 2018
DOI: 10.15761/ndt.1000129 ↗Abstract
Kein Abstract verfügbar.
EUVIMED